TrialDiabetes, obesity & metabolism2011

Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study.

R Gomis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.